Document Detail

Predictors of benefit in angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus nonresponders.
MedLine Citation:
PMID:  15832028     Owner:  NLM     Status:  MEDLINE    
Enhanced external counterpulsation (EECP) has been shown to reduce Canadian Cardiovascular Society angina class. This study examines the factors that affect the reduction at 1 year, especially in patients who do not demonstrate an initial response. The data of 2,007 consecutive patients enrolled in the International EECP Patient Registry were analyzed. After 36.6 +/- 4.9 h of EECP, angina was reduced by at least one class in 82.7%. At 1 year, 35.4% of initial nonresponders and 70.6% of responders remained improved by at least one angina class and free of major adverse cardiovascular events. Multivariate predictors of 1-year benefit are initial response to treatment (odds ratio 4.5, 95% CI 3.5-5.8), baseline angina class compared with class IV (odds ratios: class I 2.1, CI 0.93-4.81; class II 0.62, CI 0.43-0.87; class III 0.80, CI 0.62-1.01) and no history of congestive heart failure (odds ratio 1.41, CI 1.14-1.74).
William E Lawson; John C K Hui; Elizabeth D Kennard; Gregory Barsness; Sheryl F Kelsey;
Related Documents :
24793078 - A randomized trial of the effectiveness of topical "abh gel" (ativan®, benadryl®, haldo...
11552898 - H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-ana...
17073248 - Completeness and accuracy of the drug treatment reporting system in dublin, ireland.
24569538 - Efficacy and safety of the probiotic lactobacillus paracasei lp-33 in allergic rhinitis...
22535858 - Botulinum toxin a for prophylactic treatment of migraine and tension headaches in adult...
9713718 - Assessment of functional status in patients with cardiac disease.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2005-04-13
Journal Detail:
Title:  Cardiology     Volume:  103     ISSN:  0008-6312     ISO Abbreviation:  Cardiology     Publication Date:  2005  
Date Detail:
Created Date:  2005-06-15     Completed Date:  2005-09-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1266406     Medline TA:  Cardiology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  201-6     Citation Subset:  IM    
Copyright Information:
Copyright 2005 S. Karger AG, Basel.
State University of New York at Stony Brook, NY 11740, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Angina Pectoris / classification,  surgery*
Angioplasty, Transluminal, Percutaneous Coronary
Chronic Disease
Cohort Studies
Coronary Artery Bypass
Counterpulsation / methods*
Follow-Up Studies
Middle Aged
Myocardial Infarction / etiology
Nitroglycerin / therapeutic use
Prospective Studies
Quality of Life
Survival Rate
Treatment Outcome
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Vasodilator Agents; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Isolated type 2 diabetes mellitus causes myocardial dysfunction that becomes worse in the presence o...
Next Document:  Heat shock protein 70 and tumor necrosis factor alpha in Taiwanese patients with dementia.